Cost Effectiveness of Ramipril in Patients with Non-Diabetic Nephropathy and Hypertension: Economic Evaluation of Ramipril Efficacy In Nephropathy (REIN) Study for Germany from the Perspective of Statutory Health Insurance

By Schädlich P.K.  

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 497-512

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Ramipril in Patients at High Risk for Cardiovascular Events: Economic Evaluation of the HOPE (Heart Outcomes Prevention Evaluation) Study for Germany from the Statutory Health Insurance Perspective

By Peter K. Schädlich  

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 955-973

Adis International

Access to resources Recommend Favorite

Effects of metoprolol and ramipril on action potentials after myocardial infarction in rats

By Wagner K.-D.   Kamkin A.   Kiseleva I.   Theres H.   Scholz H.   Gunther J.  

European Journal of Pharmacology, Vol. 388, Iss. 3, 2000-02 ,pp. : 263-266

Elsevier

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction: Results From GISSI-3 Trial

By Franzosi M.G.   Maggioni A.P.   Santoro E.   Tognoni G.   Cavalieri E.  

PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. : 337-346

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction Who were Taking Both ACE Inhibitors and β-Blockers: Subanalysis of the EPHESUS

By Zhang Zefeng   Mahoney Elizabeth M.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 55-63

Adis International

Access to resources Recommend Favorite